Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aluminiummateriale |
Is a |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminium pyro powder |
Is a |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminum isotope |
Is a |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminum welding fumes |
Is a |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminiumintoksikation |
Causative agent |
False |
Aluminium |
Inferred relationship |
Some |
1 |
Aluminum bone disease |
Causative agent |
False |
Aluminium |
Inferred relationship |
Some |
1 |
Aluminium-related osteomalacia |
Causative agent |
False |
Aluminium |
Inferred relationship |
Some |
2 |
Aluminum-related fracturing osteodystrophy |
Causative agent |
False |
Aluminium |
Inferred relationship |
Some |
2 |
Evaluation of aluminum stores |
Has measured component |
False |
Aluminium |
Inferred relationship |
Some |
|
Bauxite fibrosis of lung |
Causative agent |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminum measurement, blood |
Has measured component |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminum measurement, tissue |
Has measured component |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminium measurement, urine |
Has measured component |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminum measurement |
Has measured component |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminosis of lung |
Causative agent |
False |
Aluminium |
Inferred relationship |
Some |
1 |
Serum aluminum measurement |
Has measured component |
False |
Aluminium |
Inferred relationship |
Some |
|
Plasma aluminum measurement |
Has measured component |
False |
Aluminium |
Inferred relationship |
Some |
|
Evaluation of aluminum stores |
Component |
True |
Aluminium |
Inferred relationship |
Some |
1 |
Aluminum measurement, blood |
Component |
False |
Aluminium |
Inferred relationship |
Some |
2 |
Aluminum measurement, tissue |
Component |
False |
Aluminium |
Inferred relationship |
Some |
2 |
Aluminium measurement, urine |
Component |
False |
Aluminium |
Inferred relationship |
Some |
2 |
Aluminum measurement |
Component |
True |
Aluminium |
Inferred relationship |
Some |
1 |
Serum aluminum measurement |
Component |
False |
Aluminium |
Inferred relationship |
Some |
2 |
Plasma aluminum measurement |
Component |
False |
Aluminium |
Inferred relationship |
Some |
2 |
Aldioxa |
Is a |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminium hydroxide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminum hydroxide oral suspension BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Magnesium carbonate mixture BPC |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Aromatic magnesium carbonate mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
magnesiumtrisilicatforbindelse 250 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Magnesium trisilicate mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
magnesiumtrisilikat som pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Compound magnesium trisilicate oral powder BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Hydrotalcite 100 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
magnesiumkarbonatforbindelse som tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
magnesiumkarbonatforbindelse som pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumhydroxid + belladonna som mikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
magnesiumtrisilicat + belladonna 0,15 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumacetat 13 % øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumacetat 8 % øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminium acetate 6.5 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
antacida som kun indeholder aluminium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
antacida indeholdende aluminium og magnesium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Co-magaldrox product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing hydrotalcite (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumchlorid 20 % roll-on-opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Co-simalcite |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
astringerende middel indeholdende aluminium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing magnesium trisilicate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing magaldrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing aluminium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing aluminium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminum hydroxide [antacid] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Magaldrate 800mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminum hydroxide [nutritional use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminum acetate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumkaliumsulfat 0,244 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumkaliumsulfat 0,138 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumkaliumsulfat 0,28 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumkaliumsulfat 0,68 mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumsulfat 0,2 mg/10 mm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumsulfat 0,45 mg/10 mm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumsulfat 0,48 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumsulfat 0,35 mg/10 mm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumsulfat 15 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumsulfat 0,85 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumsulfat 25 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumsulfat 1,45 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumsulfat 0,5 mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Aluminium chloride 250 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumchlorid 250 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumhydroxid + belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
magnesiumtrisilikat + belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing aluminium sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
dimeticon 125 mg + hydrotalcit 500 mg sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Allergy to aluminium |
Causative agent |
False |
Aluminium |
Inferred relationship |
Some |
|
Co-simalcite suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumchlorid + alkohol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing magaldrate and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing aluminium hydroxide and magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing alginic acid and aluminium hydroxide and magnesium trisilicate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing precisely magaldrate 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing aluminium hydroxide and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing hydrotalcite and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing aluminium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
aluminiumhydroxid + dimethicon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing magnesium carbonate and magnesium trisilicate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Measurement of aluminium in 24 hour urine specimen |
Component |
False |
Aluminium |
Inferred relationship |
Some |
2 |
Allergy to aluminium |
Causative agent |
True |
Aluminium |
Inferred relationship |
Some |
1 |
Product containing aluminum in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
|
Product containing aluminium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium |
Inferred relationship |
Some |
1 |
Product containing aluminium in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium |
Inferred relationship |
Some |
1 |
Aluminium-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium |
Inferred relationship |
Some |
1 |
Aluminium-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium |
Inferred relationship |
Some |
1 |
Product containing only aluminium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium |
Inferred relationship |
Some |
1 |